8 Things Doctors and Patients Should Know about the Pfizer COVID19 Vaccine

Send us a text

8 Things Doctors and Patients Should Know about the Pfizer COVID19 Vaccine

The U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) to Pfizer-BioNTech’s COVID-19 vaccine on Dec. 11. The vaccine is given in two doses that are 21 days apart from each other and is reported to be 95% effective at preventing COVID-19.

he authorization and distribution of the vaccine has raised a number of questions among physicians and the public. To help offset vaccine hesitancy, three AMA experts recently sat down to try and answer these questions during a two-part AMA COVID-19 Update. The panelists were:

• Sandra Fryhofer, MD, internal medicine physician, adjunct associate professor of medicine at Emory University School of Medicine, AMA Board of Trustees member, and AMA Liaison to the Advisory Council on Immunization Practices (ACIP)
• Shannon Curtis, assistant director, Federal Affairs for the AMA
• Marcus Plescia, MD, chief medical officer, Association of State and Territorial Health Officials (ASTHO), ASTHO Liaison to ACIP

The three discussed what physicians need to know about the Pfizer vaccine and how to counsel patients on vaccine allocation.

Support the Podcast:  https://www.buzzsprout.com/1590358/support

Closing of ReThink

Buzzsprout - Let's get your podcast launched! 
Start for FREE

Support the show